Cingolani C, Rogers B, Lu L, Kachi S, Shen J, Campochiaro PA
With BPC-157 characterised as neuroprotective and neuroregenerative across traumatic brain injury, spinal cord injury, and peripheral nerve injury models through dopaminergic and serotonergic system modulation, NO-dependent neuroprotection, and promotion of axonal outgrowth
BMO Capital Markets called the event a test case for the world in a Tuesday evening note
Addyi Also called the little pink pill, Addyi is the only FDA-approved prescription pill to treat hypoactive sexual desire disorder (HSDD)
Shipping and access: We checked for cold-safe packing and US delivery, or a quote-based supply
The post is explicit that no robust clinical trials confirm this specific pairing outperforms either agent used alone